[시장보고서]세계의 수술 부위 감염 관리 시장 : 시장 규모, 점유율 및 동향 분석(제품별, 시술별, 감염 유형별, 최종 용도별, 지역별), 부문별 예측(2025-2033년)

세계의 수술 부위 감염 관리 시장 : 시장 규모, 점유율 및 동향 분석(제품별, 시술별, 감염 유형별, 최종 용도별, 지역별), 부문별 예측(2025-2033년)

Surgical Site Infection Control Market Size, Share & Trends Analysis Report By Product (Manual Reprocessors Solution), By Procedure, By Type Of Infection, By End Use, By Region, And Segment Forecasts, 2025 - 2033

상품코드 : 1842370

리서치사 : Grand View Research

발행일 : 2025년 09월

페이지 정보 : 영문 150 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,830,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,315,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,283,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

수술 부위 감염 관리 : 시장 개요

세계의 수술 부위 감염 관리 시장 규모는 2024년에 75억 7,000만 달러로 평가되었습니다. 2033년에는 162억 2,000만 달러에 이르고, 2025년부터 2033년까지 연평균 복합 성장률(CAGR)은 8.73%를 보일 전망입니다.

이러한 성장은 암, 심혈관 질환, 당뇨병과 같은 만성 질환의 유병률 증가와 전 세계적으로 시행되는 수술 건수 증가에 기인합니다.

또한, 수술 감염의 위험과 합병증에 대한 의료 전문가와 환자의 인식이 높아지면서 환자의 안전과 질 높은 치료에 대한 중요성이 강조되고 있습니다. 항균 봉합사, 특수 상처 드레싱, 멸균 도구 등의 기술 혁신도 감염 관리 전략의 효과를 높이고 있습니다.

수술 부위 감염 관리 시장 : 제품별 대시보드
동향과 시장 점유율 분석 : 제품별(2024년·2033년)
제품별
- 수동 재처리 솔루션
- 소독제
- 수술용 스크럽
- 헤어 클리퍼
- 수술용 드레이프
- 수술용 관류액
- 피부 소독 용액
- 의료용 부직포
- 수술용 장갑
- 기타

제5장 수술 부위 감염 관리 시장 : 시술별 추정·동향 분석

수술 부위 감염 관리 시장 : 시술별 대시보드
동향과 시장 점유율 분석 : 시술별(2024년·2033년)
시술별
- 백내장 수술
- 제왕 절개
- 치과 수복
- 위 우회술
- 기타

제6장 수술 부위 감염 관리 시장 : 감염 유형별 추정·동향 분석

수술 부위 감염 관리 시장 : 감염 유형별 대시보드
동향과 시장 점유율 분석 : 감염 유형별(2024년·2033년)
감염 유형별
- Superficial Incisional SSI
- Deep Incisional SSI
- Organ SSI

제7장 수술 부위 감염 관리 시장 : 최종 용도별 추정·동향 분석

수술 부위 감염 관리 시장 : 최종 용도별 대시보드
동향과 시장 점유율 분석 : 최종 용도별(2024년·2033년)
최종 용도별
- 병원
- 외래수술센터(ASC)

제8장 수술 부위 감염 관리 시장 : 지역별 추정·동향 분석

시장 점유율 분석 : 지역별(2024년·2033년)
시장 대시보드 : 지역별
세계 시장 스냅숏 : 지역별
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 스웨덴
- 덴마크
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제9장 경쟁 구도

주요 시장 진출기업의 최근 동향과 영향 분석
기업/경쟁 분류
주요 기업 시장 현황 분석(2024년)
기업 리스트
- Getinge Group
- Steris Healthcare
- 3M
- BD
- BELIMED INC.
- POLYMERFILMS
- ANSELL LTD.
- Olympus Corporation
- Systec GmbH & Co. KG
- Ecolab Inc.
- MMM Group
- Pal International
- Miele Group
- Belimed AG

LSH

영문 목차

영문목차

Surgical Site Infection Control Market Summary

The global surgical site infection control market size was estimated at USD 7.57 billion in 2024 and is expected to reach USD 16.22 billion by 2033, growing at a CAGR of 8.73% from 2025 to 2033. This growth is attributed to the growing number of surgical procedures being conducted globally, driven by the rising incidence of chronic illnesses such as cancer, cardiovascular diseases, and diabetes.

Moreover, heightened awareness among healthcare professionals and patients about the risks and complications of surgical infections has intensified the emphasis on patient safety and quality care. Innovations in technology, such as antimicrobial sutures, specialized wound dressings, and sterilization tools, are also enhancing the effectiveness of infection control strategies.

Global Surgical Site Infection Control Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global surgical site infection (SSI) control market report based on product, procedure, type of infection, end use, and region:

Product Outlook (Revenue, USD Million, 2021 - 2033)
Manual Reprocessors Solution
Disinfectants
- Hand Disinfectants
- Skin Disinfectants
Surgical Scrubs
Hair Clippers
Surgical Drapes
Surgical Irrigation
Skin Preparation Solution
Medical Nonwovens
Surgical Gloves
Others
Procedure Outlook (Revenue, USD Million, 2021 - 2033)
Cataract Surgery
Cesarean Section
Dental Restoration
Gastric Bypass
Others
Type of Infection Outlook (Revenue, USD Million, 2021 - 2033)
Superficial Incisional SSI
Deep Incisional SSI
Organ SSI
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals
Ambulatory Surgical Centers
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1 Market Segmentation & Scope
1.2 Segment Definitions
- 1.2.1 Product
- 1.2.2 Procedure
- 1.2.3 Type of Infection
- 1.2.4 End Use
1.3 Research Methodology
- 1.3.1 Commodity flow analysis
- 1.3.2 Information procurement
  - 1.3.2.1 Purchased database
  - 1.3.2.2 GVR's internal database
  - 1.3.2.3 Primary research
1.4 Information or Data Analysis
- 1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 List of Secondary Sources
1.7 List of Abbreviations
1.8 Objectives

Chapter 2. Executive Summary

2.1 Market Snapshot
2.2 Market Segmentation
2.4 Competitive Landscape

Chapter 3. Market Variables, Trends & Scope

3.1 Market Lineage Outlook
3.2 Market Dynamics
- 3.2.1 Market Driver Analysis
- 3.2.2 Market Restraint Analysis
3.3 Industry Analysis Tools
- 3.3.1 Porter's Five Forces Analysis
- 3.3.2 PESTLE Analysis

Chapter 4. Surgical Site Infection Control Market: Product Estimates & Trend Analysis

4.1 Surgical Site Infection Control Market: Product Segment Dashboard
4.2 Product Movement & Market Share Analysis, 2024 & 2033
4.3 Global Surgical Site Infection Control Market Size Estimates & Forecast, by Product
- 4.3.1 Manual Reprocessors Solution
  - 4.3.1.1 Manual Reprocessors Solution Market, 2021 - 2033 (USD Million)
- 4.3.2 Disinfectants
  - 4.3.2.1 Disinfectants Market, 2021 - 2033 (USD Million)
  - 4.3.2.2 Hand Disinfectants Market, 2021 - 2033 (USD Million)
    - 4.3.2.2.1 Hand Disinfectants Market, 2021 - 2033 (USD Million)
  - 4.3.2.3 Skin Disinfectants Market, 2021 - 2033 (USD Million)
    - 4.3.2.3.1 Skin Disinfectants Market, 2021 - 2033 (USD Million)
- 4.3.3 Surgical Scrubs
  - 4.3.3.1 Surgical Scrubs Market, 2021 - 2033 (USD Million)
- 4.3.4 Hair Clippers
  - 4.3.4.1 Hair Clippers Market, 2021 - 2033 (USD Million)
- 4.3.5 Surgical Drapes
  - 4.3.5.1 Surgical Drapes Market, 2021 - 2033 (USD Million)
- 4.3.6 Surgical Irrigation
  - 4.3.6.1 Surgical Irrigation Market, 2021 - 2033 (USD Million)
- 4.3.7 Skin Preparation Solution
  - 4.3.7.1 Skin Preparation Solution Market, 2021 - 2033 (USD Million)
- 4.3.8 Medical Nonwovens
  - 4.3.8.1 Medical Nonwovens Market, 2021 - 2033 (USD Million)
- 4.3.9 Surgical Gloves
  - 4.3.9.1 Surgical Gloves Market, 2021 - 2033 (USD Million)
- 4.3.10 Others
  - 4.3.10.1 Others Market, 2021 - 2033 (USD Million)

Chapter 5. Surgical Site Infection Control Market: Procedure Estimates & Trend Analysis

5.1 Surgical Site Infection Control Market: Procedure Segment Dashboard
5.2 Procedure Movement & Market Share Analysis, 2024 & 2033
5.3 Global Surgical Site Infection Control Market Size Estimates & Forecast, by Procedure
- 5.3.1 Cataract Surgery
  - 5.3.1.1 Cataract Surgery Market, 2021 - 2033 (USD Million)
- 5.3.2 Cesarean Section
  - 5.3.2.1 Cesarean Section Market, 2021 - 2033 (USD Million)
- 5.3.3 Dental Restoration
  - 5.3.3.1 Dental Restoration Market, 2021 - 2033 (USD Million)
- 5.3.4 Gastric Bypass
  - 5.3.4.1 Gastric Bypass Market, 2021 - 2033 (USD Million)
- 5.3.5 Others
  - 5.3.5.1 Others Market, 2021 - 2033 (USD Million)

Chapter 6. Surgical Site Infection Control Market: Type of Infection Estimates & Trend Analysis

6.1 Surgical Site Infection Control Market: Type of Infection Segment Dashboard
6.2 Type of Infection Movement & Market Share Analysis, 2024 & 2033
6.3 Global Surgical Site Infection Control Market Size Estimates & Forecast, by Type of Infection
- 6.3.1 Superficial Incisional SSI
  - 6.3.1.1 Superficial Incisional SSI Market, 2021 - 2033 (USD Million)
- 6.3.2 Deep Incisional SSI
  - 6.3.2.1 Deep Incisional SSI Market, 2021 - 2033 (USD Million)
- 6.3.3 Organ SSI
  - 6.3.3.1 Organ or Space SSI Market, 2021 - 2033 (USD Million)

Chapter 7. Surgical Site Infection Control Market: End Use Estimates & Trend Analysis

7.1 Surgical Site Infection Control Market: End Use Segment Dashboard
7.2 End Use Movement & Market Share Analysis, 2024 & 2033
7.3 Global Surgical Site Infection Control Market Size Estimates & Forecast, by End Use
- 7.3.1 Hospitals
  - 7.3.1.1 Hospitals Market, 2021 - 2033 (USD Million)
- 7.3.2 Ambulatory Surgical Centers
  - 7.3.2.1 Ambulatory Surgical Centers Market, 2021 - 2033 (USD Million)

Chapter 8. Surgical Site Infection Control Market: Regional Estimates & Trend Analysis

8.1. Regional Market Share Analysis, 2024 & 2033
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. North America
- 8.4.1. U.S.
  - 8.4.1.1. Key country dynamics
  - 8.4.1.2. Regulatory framework
  - 8.4.1.3. Competitive scenario
  - 8.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.2. Canada
  - 8.4.2.1. Key country dynamics
  - 8.4.2.2. Regulatory framework
  - 8.4.2.3. Competitive scenario
  - 8.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.3. Mexico
  - 8.4.3.1. Key country dynamics
  - 8.4.3.2. Regulatory framework
  - 8.4.3.3. Competitive scenario
  - 8.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
8.5. Europe
- 8.5.1. UK
  - 8.5.1.1. Key country dynamics
  - 8.5.1.2. Regulatory framework
  - 8.5.1.3. Competitive scenario
  - 8.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.2. Germany
  - 8.5.2.1. Key country dynamics
  - 8.5.2.2. Regulatory framework
  - 8.5.2.3. Competitive scenario
  - 8.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.3. France
  - 8.5.3.1. Key country dynamics
  - 8.5.3.2. Regulatory framework
  - 8.5.3.3. Competitive scenario
  - 8.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.4. Italy
  - 8.5.4.1. Key country dynamics
  - 8.5.4.2. Regulatory framework
  - 8.5.4.3. Competitive scenario
  - 8.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.5. Spain
  - 8.5.5.1. Key country dynamics
  - 8.5.5.2. Regulatory framework
  - 8.5.5.3. Competitive scenario
  - 8.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.6. Norway
  - 8.5.6.1. Key country dynamics
  - 8.5.6.2. Regulatory framework
  - 8.5.6.3. Competitive scenario
  - 8.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.7. Sweden
  - 8.5.7.1. Key country dynamics
  - 8.5.7.2. Regulatory framework
  - 8.5.7.3. Competitive scenario
  - 8.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.8. Denmark
  - 8.5.8.1. Key country dynamics
  - 8.5.8.2. Regulatory framework
  - 8.5.8.3. Competitive scenario
  - 8.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
8.6. Asia Pacific
- 8.6.1. Japan
  - 8.6.1.1. Key country dynamics
  - 8.6.1.2. Regulatory framework
  - 8.6.1.3. Competitive scenario
  - 8.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.2. China
  - 8.6.2.1. Key country dynamics
  - 8.6.2.2. Regulatory framework
  - 8.6.2.3. Competitive scenario
  - 8.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.3. India
  - 8.6.3.1. Key country dynamics
  - 8.6.3.2. Regulatory framework
  - 8.6.3.3. Competitive scenario
  - 8.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.4. Australia
  - 8.6.4.1. Key country dynamics
  - 8.6.4.2. Regulatory framework
  - 8.6.4.3. Competitive scenario
  - 8.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.5. South Korea
  - 8.6.5.1. Key country dynamics
  - 8.6.5.2. Regulatory framework
  - 8.6.5.3. Competitive scenario
  - 8.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.6. Thailand
  - 8.6.6.1. Key country dynamics
  - 8.6.6.2. Regulatory framework
  - 8.6.6.3. Competitive scenario
  - 8.6.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
8.7. Latin America
- 8.7.1. Brazil
  - 8.7.1.1. Key country dynamics
  - 8.7.1.2. Regulatory framework
  - 8.7.1.3. Competitive scenario
  - 8.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.2. Argentina
  - 8.7.2.1. Key country dynamics
  - 8.7.2.2. Regulatory framework
  - 8.7.2.3. Competitive scenario
  - 8.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
8.8. MEA
- 8.8.1. South Africa
  - 8.8.1.1. Key country dynamics
  - 8.8.1.2. Regulatory framework
  - 8.8.1.3. Competitive scenario
  - 8.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8.2. Saudi Arabia
  - 8.8.2.1. Key country dynamics
  - 8.8.2.2. Regulatory framework
  - 8.8.2.3. Competitive scenario
  - 8.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8.3. UAE
  - 8.8.3.1. Key country dynamics
  - 8.8.3.2. Regulatory framework
  - 8.8.3.3. Competitive scenario
  - 8.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8.4. Kuwait
  - 8.8.4.1. Key country dynamics
  - 8.8.4.2. Regulatory framework
  - 8.8.4.3. Competitive scenario
  - 8.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Key company market position analysis, 2024
9.4. List of Companies
- 9.4.1. Getinge Group
  - 9.4.1.1. Company overview
  - 9.4.1.2. Financial performance
  - 9.4.1.3. Product benchmarking
  - 9.4.1.4. Strategic initiatives
- 9.4.2. Steris Healthcare
  - 9.4.2.1. Company overview
  - 9.4.2.2. Financial performance
  - 9.4.2.3. Product benchmarking
  - 9.4.2.4. Strategic initiatives
- 9.4.3. 3M
  - 9.4.3.1. Company overview
  - 9.4.3.2. Financial performance
  - 9.4.3.3. Product benchmarking
  - 9.4.3.4. Strategic initiatives
- 9.4.4. BD
  - 9.4.4.1. Company overview
  - 9.4.4.2. Financial performance
  - 9.4.4.3. Product benchmarking
  - 9.4.4.4. Strategic initiatives
- 9.4.5. BELIMED INC.
  - 9.4.5.1. Company overview
  - 9.4.5.2. Financial performance
  - 9.4.5.3. Product benchmarking
  - 9.4.5.4. Strategic initiatives
- 9.4.6. POLYMERFILMS
  - 9.4.6.1. Company overview
  - 9.4.6.2. Financial performance
  - 9.4.6.3. Product benchmarking
  - 9.4.6.4. Strategic initiatives
- 9.4.7. ANSELL LTD.
  - 9.4.7.1. Company overview
  - 9.4.7.2. Financial performance
  - 9.4.7.3. Product benchmarking
  - 9.4.7.4. Strategic initiatives
- 9.4.8. Olympus Corporation
  - 9.4.8.1. Company overview
  - 9.4.8.2. Financial performance
  - 9.4.8.3. Product benchmarking
  - 9.4.8.4. Strategic initiatives
- 9.4.9. Systec GmbH & Co. KG
  - 9.4.9.1. Company overview
  - 9.4.9.2. Financial performance
  - 9.4.9.3. Product benchmarking
  - 9.4.9.4. Strategic initiatives
- 9.4.10. Ecolab Inc.
  - 9.4.10.1. Company overview
  - 9.4.10.2. Financial performance
  - 9.4.10.3. Product benchmarking
  - 9.4.10.4. Strategic initiatives
- 9.4.11. MMM Group
  - 9.4.11.1. Company overview
  - 9.4.11.2. Financial performance
  - 9.4.11.3. Product benchmarking
  - 9.4.11.4. Strategic initiatives
- 9.4.12. Pal International
  - 9.4.12.1. Company overview
  - 9.4.12.2. Financial performance
  - 9.4.12.3. Product benchmarking
  - 9.4.12.4. Strategic initiatives
- 9.4.13. Miele Group
  - 9.4.13.1. Company overview
  - 9.4.13.2. Financial performance
  - 9.4.13.3. Product benchmarking
  - 9.4.13.4. Strategic initiatives
- 9.4.14. Belimed AG
  - 9.4.14.1. Company overview
  - 9.4.14.2. Financial performance
  - 9.4.14.3. Product benchmarking
  - 9.4.14.4. Strategic initiatives